Controlled agglomeration

Details for Australian Patent Application No. 2002325192 (hide)

Owner LifeCycle Pharma A/S

Inventors Mollgaard, Birgitte; Buur, Anders; Schultz, Kirsten; Holm, Jannie, Egeskov; Elema, Michiel, Onne; Holm, Per

Agent FB Rice

Pub. Number AU-B-2002325192

PCT Number PCT/DK02/00472

PCT Pub. Number WO2003/004001

Priority PA 2001 01071 06.07.01 DK

Filing date 5 July 2002

Wipo publication date 21 January 2003

Acceptance publication date 22 May 2008

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

B01J 2/00 (2006.01) Processes or devices for granulating materials, in general

B01J 2/02 (2006.01) Processes or devices for granulating materials, in general - by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): PA 2001 01071 06.07.01 DK

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002325192

22 May 2008 Application Accepted

  Published as AU-B-2002325192

18 September 2008 Standard Patent Sealed

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

28 April 2011 Section 223 Application Received

  LifeCycle Pharma A/S An application to extend the time from 05 Jul 2010 to 05 Feb 2011 in which to pay a renewal fee has been filed . Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000 2003

16 June 2011 Section 223 Application Allowed

  LifeCycle Pharma A/S The time in which to pay a renewal fee has been extended to 05 Feb 2011. Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000 2003

4 August 2011 Alteration of Name

  The name of the patentee has been altered to Veloxis Pharmaceuticals A/S 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325193-A P387L VARIANT IN PROTEIN TYROSINE PHOSPHATASE-1B IS ASSOCIATED WITH TYPE 2 DIABETES AND IMPAIRED SERINE PHOSPHORYLATION OF PTP-1B IN VITRO

2002325191-A fencing